Emily English
Chief Executive Officer at Gemstone Biotherapeutics LLC
Net worth: - $ as of 2024-04-29
Profile
Emily P.
English is currently the Chief Executive Officer at Gemstone Biotherapeutics LLC and the SVP & Head-Manufacturing Operations at Cartesian Therapeutics, Inc. She previously worked as the Chief Executive Officer at The Johns Hopkins University.
Dr. English holds a doctorate degree from the University of Wisconsin and an undergraduate degree from the University of Maryland.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
-.--% | 2024-04-17 | 0 ( -.--% ) | - $ | 2024-04-29 |
Emily English active positions
Companies | Position | Start |
---|---|---|
Gemstone Biotherapeutics LLC
Gemstone Biotherapeutics LLC BiotechnologyHealth Technology Gemstone Biotherapeutics LLC develops therapeutics and devices for wound care. It develops a range of tissue engineering inventions with particular emphasis on vascularization and angiogenesis for health care research and clinical markets. The company was founded in October 2013 and is headquartered in Baltimore, MD. | Chief Executive Officer | - |
Former positions of Emily English
Companies | Position | End |
---|---|---|
The Johns Hopkins University | Chief Executive Officer | - |
Training of Emily English
University of Wisconsin | Doctorate Degree |
University of Maryland | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Gemstone Biotherapeutics LLC
Gemstone Biotherapeutics LLC BiotechnologyHealth Technology Gemstone Biotherapeutics LLC develops therapeutics and devices for wound care. It develops a range of tissue engineering inventions with particular emphasis on vascularization and angiogenesis for health care research and clinical markets. The company was founded in October 2013 and is headquartered in Baltimore, MD. | Health Technology |
- Stock Market
- Insiders
- Emily English